Martínez, E., Arranz, J., Podzamczer, D., Lonca, M., Sanz, J., Barragán, P., . . . Gatell, J. (2010). Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study. The International AIDS Society.
Styl cytowania ChicagoMartínez, E., et al. Long-term Outcomes of Switching to Fixed-dose Abacavir/lamivudine (ABC/3TC) or Tenofovir/emtricitabine (TDF/FTC): 3-year Results of the BICOMBO Study. The International AIDS Society, 2010.
Styl cytowania MLAMartínez, E., et al. Long-term Outcomes of Switching to Fixed-dose Abacavir/lamivudine (ABC/3TC) or Tenofovir/emtricitabine (TDF/FTC): 3-year Results of the BICOMBO Study. The International AIDS Society, 2010.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..